Specialized Data and AI for Research and Personalized Medicine

Founded in 2015, OM1 is focused on transforming healthcare by reimagining how it is measured and delivered. With specialization in chronic and auto-immune diseases, OM1 is a leading real-world data, outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes.

Leveraging data on more than 300 million patients, we deliver:

• Specialized, prospective, linked datasets in Rheumatology, Dermatology, Cardiometabolic, Neuroscience, Gastroenterology, and Respiratory for research, advanced analytics and more.
• Custom, linked and normalized data networks in additional areas such as oncology and rare diseases for answering challenging research questions and meeting regulatory requirements
• AI enabled models and tools to help target specialized patient populations, to find patients with undiagnosed disease, and to predict outcomes